Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 10/20 | 0.41 |
| ▸ | MMP2 | P08253 | 9/20 | 0.41 |
| ▸ | MMP1 | P03956 | 8/20 | 0.41 |
| ▸ | MMP7 | P09237 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19608618 | 0.90 | BIRC2 (0.46) | BIRC2CA2EPHX1MAPTMMP3 | |
| SCHEMBL21538503 | 0.83 | HDAC7 (0.46) | BIRC2CA2MMP3MMP2MMP1 | |
| SCHEMBL20942699 | 0.83 | CA2 (0.49) | BIRC2CA2MMP3MMP2MMP1 | |
| SCHEMBL24419530 | 0.80 | BIRC2 (0.43) | BIRC2CA2MMP3MMP2MMP1 | |
| SCHEMBL21250702 | 0.80 | CA2 (0.52) | BIRC2CA2EPHX1MAPTCA1 | |
| SCHEMBL26030776 | 0.80 | CA2 (0.52) | BIRC2CA2EPHX1MAPTCA1 | |
| SCHEMBL18612532 | 0.80 | CA2 (0.52) | BIRC2CA2EPHX1MAPTCA1 | |
| SCHEMBL8431170 | 0.80 | CA2 (0.52) | BIRC2CA2EPHX1MAPTCA1 | |
| SCHEMBL28601020 | 0.80 | CA2 (0.52) | BIRC2CA2EPHX1MAPTCA1 | |
| SCHEMBL22857535 | 0.78 | GNAI3 (0.56) | CA2EPHX1GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170355714-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-12-14 | — | — | US | disclosed |
| US-20170325459-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170325459-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | DDT, BCHE, BAK1 | BIRC2 8/4885CA2 3307/4885EPHX1 745/4885 |
| US-20170355714-A1 | BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | DDT, BCHE, BAK1 | BIRC2 15/4885CA2 2935/4885EPHX1 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.